There were 1,808 press releases posted in the last 24 hours and 428,257 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Capnia Enrolls First Patient in Phase 2 Clinical Trial Evaluating Nasal CO2 for the Symptomatic Treatment of Trigeminal Neuralgia

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image